AtriCure, Inc. (ATRC) stock forecast and price target
Price $56.84 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($56.84)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $0.43 | +488.0% | $608M |
| Next fiscal year ends December 31, 2027 | $0.46 | +7.8% | $682M |
| Next quarter ends December 31, 2026 | $0.07 | +14.1% | $160M |
| Quarter after ends March 31, 2027 | $0.03 | +0.0% | $159M |
Consensus of the analysts covering AtriCure, updated daily. In the last 30 days 6 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 14.2% upside over 12 months. Our discounted cash flow model with moderate assumptions puts AtriCure’s intrinsic value about 92% below today’s market value, and it scores 1.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the AtriCure stock price target?
The average 12-month target from 9 analysts is $64.89, 14.2% above the current price of $56.84 Targets range from $50.00 to $70.00.
Is AtriCure a buy according to analysts?
The consensus rating is “Buy” (3 strong buy, 4 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is AtriCure expected to earn?
Analysts expect EPS of $0.43 for the fiscal year ending December 31, 2026 and $0.46 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.